Jazz Pharmaceuticals plc Share Price & Technical Analysis
JAZZ · $237.4 (-1.03%)
Healthcare / Biotechnology
$237.4
-1.03%
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC);…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
16% return in May, -7% avg return in past 3 year May month.
35% return in 2026, 8% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -3% | 15% | 0% | 7% | 16% | – | – | – | – | – | – | – | 35% |
| 25 | 1% | 17% | -14% | -5% | -7% | -2% | 9% | 13% | 4% | 4% | 29% | -2% | 46% |
| 24 | 0% | -3% | 1% | -8% | -4% | 1% | 3% | 2% | -1% | -1% | 10% | 2% | 2% |
| 23 | -2% | -10% | 5% | -4% | -9% | -3% | 6% | 10% | -10% | -1% | -8% | 4% | -23% |
| 22 | 8% | -1% | 15% | 3% | -6% | 4% | 0% | 0% | -13% | 7% | 9% | 1% | 27% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$14.27B
P/E ratio
2067.36
52W high
$243.3
52W low
$105.0
Volume
4,03,026
Beta
0.27
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Jazz Pharmaceuticals plc share price today?
- Jazz Pharmaceuticals plc (JAZZ) last traded around $237.4 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does JAZZ have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for JAZZ. Download the app for real-time alerts.
- How can I analyze Jazz Pharmaceuticals plc stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.